Page last updated: 2024-08-26

cp-55,940 and delta-8-tetrahydrocannabinol

cp-55,940 has been researched along with delta-8-tetrahydrocannabinol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gynther, J; Järvinen, T; Lahtela-Kakkonen, M; Laitinen, JT; Nevalainen, T; Parkkari, T; Poso, A; Salo, OM; Savinainen, JR1
Buzard, DJ; Han, S; Jones, RM; Thatte, J1

Reviews

1 review(s) available for cp-55,940 and delta-8-tetrahydrocannabinol

ArticleYear
Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.
    Journal of medicinal chemistry, 2013, Nov-14, Volume: 56, Issue:21

    Topics: Animals; Drug Design; Humans; Ligands; Models, Molecular; Molecular Conformation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Substrate Specificity

2013

Other Studies

1 other study(ies) available for cp-55,940 and delta-8-tetrahydrocannabinol

ArticleYear
3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data.
    Journal of medicinal chemistry, 2006, Jan-26, Volume: 49, Issue:2

    Topics: Animals; Cannabinoid Receptor Modulators; Cerebellum; GTP-Binding Proteins; In Vitro Techniques; Ligands; Male; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Radioligand Assay; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1

2006